Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

Abstract Purpose: The oncogenic miR-155 is upregulated in many humancancers,anditsexpressionisincreasedinmoreaggressive and therapy-resistant tumors, but the molecular mechanisms underlying miR-155-induced therapy resistance are not fully understood. The main objectives of this study were to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Roosbroeck, Katrien, Fanini, Francesca, Setoyama, Tetsuro, Ivan, Cristina, Rodríguez Aguayo, Cristian, Fuentes Mattei, Enrique, Xiao, Lianchun, Vannini, Ivan, Redis, Roxana S., D'Abundo, Lucilla, Zhang, Xinna, Nicoloso, Milena S., Rossi, Simona, González Villasana, Vianey, Rupaimoole, Rajesha, Ferracin, Manuela, Morabito, Fortunato, Neri, Antonino, Ruvolo, Peter P., Ruvolo, Vivian R., Pecot, Chad V., Amadori, Dino, Abruzzo, Lynne V., Calin, Steliana, Wang, Xuemei, You, M. James, Ferrajoli, Alessandra, Orlowski, Robert, Plunkett, William, Lichtenberg, Tara M., Davuluri, Ramana V., Berindan Neagoe, Ioana, Negrini, Massimo, Wistuba, Ignacio I., Kantarjian, Hagop M., Sood, Anil K., Lopez Berestein, Gabriel, Keating, Michael J., Fabbri, L. Muller, Calin, George A.
Formato: Artículo
Lenguaje:English
Publicado: 2016
Acceso en línea:http://eprints.uanl.mx/18044/1/391.pdf

Ejemplares similares